Literature DB >> 30480056

Refractory Chronic Pouchitis and Autoimmune Hemolytic Anemia Successfully Treated with Vedolizumab.

Diana Martins1, Paula Ministro1, Américo Silva1.   

Abstract

Entities:  

Keywords:  Hemolytic anemia; Pouchitis; Ulcerative colitis; Vedolizumab

Year:  2018        PMID： 30480056      PMCID： PMC6243957          DOI： 10.1159/000486803

Source DB:  PubMed          Journal:  GE Port J Gastroenterol        ISSN： 2387-1954


× No keyword cloud information.
  5 in total

1.  Autoimmune cytopenias associated with inflammatory bowel diseases: Insights from a multicenter retrospective cohort.

Authors:  Mathieu Uzzan; Lionel Galicier; Jean-Marc Gornet; Eric Oksenhendler; Claire Fieschi; Matthieu Allez; Yoram Bouhnik; Julien Kirchgesner; David Boutboul; Xavier Treton; Laurence Gérard; Matthieu Mahévas; Jacques Cosnes; Aurélien Amiot
Journal:  Dig Liver Dis       Date:  2016-12-23       Impact factor: 4.088

Review 2.  Systematic review: outcomes and post-operative complications following colectomy for ulcerative colitis.

Authors:  L Peyrin-Biroulet; A Germain; A S Patel; J O Lindsay
Journal:  Aliment Pharmacol Ther       Date:  2016-08-17       Impact factor: 8.171

3.  Efficacy of Vedolizumab in Patients with Antibiotic and Anti-tumor Necrosis Alpha Refractory Pouchitis.

Authors:  Jessica Philpott; Jean Ashburn; Bo Shen
Journal:  Inflamm Bowel Dis       Date:  2017-01       Impact factor: 5.325

Review 4.  Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm.

Authors:  J P Segal; N S Ding; G Worley; S Mclaughlin; S Preston; O D Faiz; S K Clark; A L Hart
Journal:  Aliment Pharmacol Ther       Date:  2016-12-23       Impact factor: 8.171

5.  Vedolizumab as induction and maintenance therapy for ulcerative colitis.

Authors:  Brian G Feagan; Paul Rutgeerts; Bruce E Sands; Stephen Hanauer; Jean-Frédéric Colombel; William J Sandborn; Gert Van Assche; Jeffrey Axler; Hyo-Jong Kim; Silvio Danese; Irving Fox; Catherine Milch; Serap Sankoh; Tim Wyant; Jing Xu; Asit Parikh
Journal:  N Engl J Med       Date:  2013-08-22       Impact factor: 91.245
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.